Compugen (CGEN) Retained Earnings (2009 - 2025)
Compugen's (CGEN) quarterly Retained Earnings came in at -$453.4 million in Q4 2025, up 7.23% year-on-year from -$422.8 million in Q4 2024, and up 9.91% quarter-over-quarter from -$503.3 million in Q2 2025.
Compugen (CGEN) Retained Earnings (2009 - 2025) Analysis & Trends
Compugen has disclosed Retained Earnings across 17 years of filings, most recently posting -$453.4 million for Q4 2025.
- Retained Earnings for Q4 2025 came in at -$453.4 million, up 7.23% year-over-year; the trailing twelve-month figure through Dec 2025 was -$453.4 million (up 7.23% YoY), and the FY2025 annual result was -$453.4 million, up 7.23% from the prior year.
- Retained Earnings came in at -$453.4 million for Q4 2025 at Compugen, up from -$503.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $2000.0 in Q4 2023 to a low of -$503.3 million in Q2 2025.
- The 5-year median for Retained Earnings is -$454.6 million (2022), against an average of -$413.0 million.
- Across the five-year window, Retained Earnings soared 100.0% in 2023 and sank 24438000.0% in 2024, its largest moves.
- Compugen's Retained Earnings stood at -$422.1 million in 2021, then fell by 7.98% to -$455.8 million in 2022, then jumped by 100.0% to $2000.0 in 2023, then tumbled by 24438000.0% to -$488.8 million in 2024, then gained by 7.23% to -$453.4 million in 2025.
- The last three Retained Earnings figures came in at -$453.4 million (Q4 2025), -$503.3 million (Q2 2025), and -$488.8 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -453.42 Mn |
| Jun 30, 2025 | -503.28 Mn |
| Dec 31, 2024 | -488.76 Mn |
| Jun 30, 2024 | -483.92 Mn |
| Dec 31, 2023 | 2,000.00 |
| Jun 30, 2023 | -474.39 Mn |
| Dec 31, 2022 | -455.77 Mn |
| Jun 30, 2022 | -440.93 Mn |
| Dec 31, 2021 | -422.08 Mn |
| Jun 30, 2021 | -407.28 Mn |
| Dec 31, 2020 | -387.88 Mn |
| Jun 30, 2020 | -371.55 Mn |
| Dec 31, 2019 | -358.18 Mn |
| Jun 30, 2019 | -345.23 Mn |
| Dec 31, 2018 | -330.84 Mn |
| Jun 30, 2018 | -318.33 Mn |
| Dec 31, 2017 | -308.24 Mn |
| Jun 30, 2017 | -289.06 Mn |
| Dec 31, 2016 | -270.97 Mn |
| Jun 30, 2016 | -254.69 Mn |